title: Is a paradigm shift in US healthcare reimbursement inevitable?
authors.affiliation: Guidant Corporation, Indianapolis, Ind, USA.
authors.forename: August M
authors.initials: AM
authors.lastname: Watanabe
authors.forename: Ronald W
authors.initials: RW
authors.lastname: Dollens
authors.forename: William N
authors.initials: WN
authors.lastname: Malatestinic
authors.forename: Robert A
authors.initials: RA
authors.lastname: Browne
mesh_terms: D003363:Cost Control; D003365:Costs and Cost Analysis; D003695:Delivery of Health Care; D004059:Diffusion of Innovation; D016527:Drug Costs; D004864:Equipment and Supplies / Q000191:economics / Q000600:supply & distribution; D005544:Forecasting; D017048:Health Care Costs; D015276:Health Care Rationing; D006291:Health Policy; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000639:trends*; D013677:Medical Laboratory Science / Q000191:economics; D008962:Models, Theoretical; D014481:United States